— Know what they know.
Not Investment Advice

GNLKQ OTC

GeneLink, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -60.0% 5Y: -95.6%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $10601 mcap · 161M float · 0.0003% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.00001-0.00004
Volume500
Avg Volume456
Beta-0.13
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBernard L. Kasten Jr.
Employees14
SectorHealthcare
IndustryBiotechnology
IPO Date1998-11-30
8240 Exchange Drive
Orlando, FL 32809
US
407-680-1150
About GeneLink, Inc.

GeneLink, Inc. specializes in delivering 12-gene DNA profiling services. Beyond genetic analyses, the company also provides clients with bespoke nutritional supplements tailored to individual health needs. Additionally, the firm crafts a comprehensive collection of dermatological products. Established in 1994, GeneLink, Inc. maintains its headquarters in Orlando, Florida.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms